U.S. Semiconductors Stock News

Green Plains (GPRE) has drawn fresh attention as investors reassess its role in low carbon fuels, with recent returns over the month and past 3 months prompting closer scrutiny of its fundamentals. See our latest analysis for Green Plains. At a share price of $16.89, Green Plains has seen a 30 day share price return of 23.02% and a 90 day share price return of 71.47%. Its 1 year total shareholder return of 247.53% contrasts with weaker 3 and 5 year total shareholder returns, suggesting strong...

Monte Rosa Therapeutics, Inc. recently reported a fourth-quarter 2025 net loss of US$46.14 million and entered a supply agreement with Johnson & Johnson to evaluate its investigational molecular glue degrader MRT-2359 in combination with ERLEADA in a planned Phase 2 study for metastatic castration-resistant prostate cancer. This collaboration, together with positive early data for MRT-2359 presented at the 2026 ASCO GU Cancers Symposium, highlights growing external interest in Monte Rosa’s...

Celcuity (CELC) has been in focus after the FDA accepted its New Drug Application for gedatolisib with priority review, while management simultaneously accelerates commercial preparation ahead of a potential launch. See our latest analysis for Celcuity. The share price has been volatile around these updates, with a 1 day share price return of negative 7.66% and a 30 day share price return of negative 5.09%. However, the 1 year total shareholder return is very large and indicates that longer...

Globus Medical, Inc. recently announced that Director John A. DeFord, PhD, resigned from its Board of Directors with immediate effect and will not stand for re-election at the June 3, 2026 Annual Meeting, leaving his role on the Nominating and Governance Committee. At the same time, new analyst coverage from Wells Fargo has drawn attention to Globus Medical’s execution, product portfolio expansion and updated 2026 outlook, sharpening focus on how governance and growth plans align. Against...

Diversified Energy recently announced a new share buyback program running through March 2027, targeting the repurchase of about 7.8 million shares and disclosing a completed buyback of 300,000 shares, while President and CFO Bradley Gray gifted 15,000 shares to family members, reducing his beneficial ownership to 212,790 shares. This combination of an expanded capital return plan and updated insider holdings offers fresh insight into how management is currently aligning with...

On March 18, 2026, Genuine Parts Company announced that Executive Vice President and Chief Information & Digital Officer Naveen Krishna had resigned, stepping down as an executive officer on April 1 while remaining until May 5 to support a transition, with his duties to be redistributed and no severance paid. The decision not to appoint a direct successor and instead spread Krishna’s responsibilities across existing leaders raises questions about how Genuine Parts will maintain momentum in...

National Fuel Gas (NYSE:NFG) entered into a new US$1.3b unsecured committed revolving credit facility with a group of major lenders. The new facility extends the company’s debt maturity profile to 2031 and amends prior credit agreements. Management plans to use the facility for repaying existing debt, general corporate purposes, and potential future investments. National Fuel Gas, a diversified energy company involved in natural gas exploration, production, gathering, and distribution, now...

Howmet Aerospace recently reported upbeat fiscal fourth-quarter results and raised its first-quarter profit guidance above analyst expectations, while also gaining visibility as one of Jim Cramer’s highlighted defense technology names. This combination of stronger-than-anticipated guidance and growing recognition for its role in supplying critical aerospace and defense components has sharpened investor focus on Howmet’s earnings power and industry positioning. Now we’ll explore how this...

If you are wondering whether Oracle's current share price reflects its true worth, you are not alone. This article is designed to help you frame that question clearly. The stock recently closed at US$139.66, with returns of 0.1% over 1 year, 55.8% over 3 years and 108.3% over 5 years. The year-to-date return sits at a 28.6% decline, and the last month shows a 3.9% decline after a 6.7% decline over the past week. Recent headlines have focused on Oracle's role as a large enterprise software...

On March 19, 2026, Hovde Group upgraded SouthState Bank Corporation from Market Perform to Outperform, shortly after CEO John C. Corbett highlighted strong returns and a fourth-quarter 2025 repurchase of 2 million shares, alongside board approval for a new 5.56 million-share buyback program. This combination of an analyst upgrade and expanded repurchase authorization underscores external and internal confidence in SouthState’s capital deployment and longer-term prospects. Next, we’ll assess...

Recent share performance and business snapshot Fortive (FTV) shares have retreated over the past month and past 3 months, with returns of 8.9% and 4.0% respectively. This has prompted some investors to reassess the company’s fundamentals and recent financial profile. The group generates revenue of about US$4.16b and net income of roughly US$532.7m. Its operations are split between its Intelligent Operating Solutions and Advanced Healthcare Solutions segments across the United States, Asia...

Kymera Therapeutics recently reported past positive Phase 1b data for KT-621, its first-in-class oral STAT6 degrader in moderate-to-severe atopic dermatitis, showing deep STAT6 reduction, broad biomarker effects and encouraging clinical improvements after 28 days of once-daily dosing. The data, presented as a late-breaking oral session at the American Academy of Dermatology meeting, highlight how Kymera’s protein degradation platform may translate into biologics-like immune modulation using...

If you are wondering whether Marsh & McLennan Companies at around US$169 is now a potential opportunity or a value trap, the key is to understand what the current price actually implies about the business. The stock has seen a 4.1% decline over the last 7 days, a 9.4% decline over 30 days and is down 29.0% over the past year, which may signal that the market is reassessing both its growth potential and risk profile. Recent coverage has focused on how the company is positioned within the...

If you are wondering whether Argan at around US$566 per share still offers value after a strong run, you are not alone. The stock has posted returns of 19.6% over the last week, 25.6% over the last month, 73.8% year to date and 313.5% over the past year, with a very large 3-year gain and a 10x return over 5 years. Recent coverage has focused on Argan's sharp share price performance and what it might imply for expectations already baked into the stock. Investors are now weighing whether these...

Recent share performance and business snapshot Versant Media Group (VSNT) has caught investor attention after a mixed stretch in the share price, with gains over the past month contrasting with weaker returns in the past 3 months and year to date. The company operates a media and entertainment portfolio focused on U.S. television programming and distribution. It has reported revenue of US$6,688 and net income of US$930, and is positioned as a mid cap name around US$5.1b. See our latest...

What recent returns on Centrus Energy tell you Centrus Energy (LEU) has seen a 5.4% decline over the past day and a 2.1% decline over the past week, extending to a 9.7% drop over the past month. Over the past 3 months the stock is down 26.6%, while year to date it is down 32.9%. This is a sharp contrast to its 176.1% total return over the past year and its very large 3-year and 5-year total returns. See our latest analysis for Centrus Energy. At a share price of $182.90, Centrus Energy is...

If you are wondering whether International Paper at around US$35.45 is a bargain or a value trap, you are not alone. This article is built to help you think that through clearly. The stock has moved 5.0% over the last 7 days, while returns of an 18.6% decline over 30 days and an 11.9% decline year to date, alongside a 30.6% decline over the past year, show how quickly sentiment around the shares can change. Recent coverage has focused on how International Paper fits into the broader...

Wondering whether General Mills at around US$36.45 is starting to look like value or still has more room to fall? This article focuses on what the current price really implies. The stock has seen sharp moves recently, with a 1.5% decline over the last week, a 19.4% decline over the last month, a 20.3% decline year to date and a 35.2% decline over the last year. The 3 year and 5 year returns sit at 52.0% and 28.5% declines respectively. These price moves have kept General Mills in focus as...

If you are wondering whether Interactive Brokers Group's current price reflects its underlying worth, the recent share performance gives you a useful starting point. The stock last closed at US$64.20, with a 1.9% decline over 7 days, a 9.8% decline over 30 days and a 4.5% decline year to date, while still showing a 56.7% return over 1 year, a 216.1% return over 3 years and 258.4% over 5 years. Recent coverage has focused on how these price moves fit into broader sentiment around online...

Wondering whether Leggett & Platt at around US$9.58 is a bargain or a value trap? This article walks you through what the current price might really be saying. The stock has recently shown mixed returns, with a 0.3% move over the last week, an 18.0% decline over the last month, a 12.8% decline year to date, a 22.4% gain over the last year, and longer term declines of 66.4% over three years and 74.7% over five years. Recent coverage has focused on Leggett & Platt's share price swings and what...

Why Aptiv Stock Is Back on Investors’ Radar Aptiv (APTV) has been drawing attention after recent share price pressure, with the stock down about 9% over the past month and 13% over the past 3 months from its recent levels. See our latest analysis for Aptiv. The recent 1 day share price return of a 5.5% decline, alongside a 30 day share price return of an 8.8% decline and a year to date share price return of a 14.5% decline, contrasts with a 1 year total shareholder return of 10.7%. This...

In recent days, analysts have been preparing for Edwards Lifesciences’ upcoming fiscal first-quarter 2026 earnings release, while Royal Philips secured FDA 510(k) clearance for its EchoNavigator R5.0 with DeviceGuide, an AI-guided imaging tool co-developed to support Edwards’ PASCAL Ace mitral valve repair device. This pairing of anticipated earnings progress and fresh FDA-cleared AI imaging support underscores Edwards’ expanding presence in transcatheter structural heart therapies and...

Why Portland General Electric (POR) is on investor radar Portland General Electric (POR) is drawing attention after a period where the share price return over the past year and past 3 months contrasts with a weaker month, prompting a closer look at fundamentals. See our latest analysis for Portland General Electric. At a share price of $51.71, Portland General Electric has a 90 day share price return of 8.07%. The 30 day share price return of 4.17% suggests recent momentum has cooled, set...

Wondering whether FirstSun Capital Bancorp at around US$36.06 is giving you good value right now? This breakdown will help you judge the price with a clear set of valuation tools. The stock has returned 1.5% over the last 7 days, while the 30 day return is a 1.1% decline and the year to date move sits at a 4.6% decline, with a 4.5% decline over the past year and a 28.8% gain over 3 years. Recent coverage has focused on the bank's position within the wider US banking sector and how regional...